Vantive sells most of its hemodialysis business to Rockwell Medical

Discussed by: Both companies, which state a mid-2027 closing target in the announcement

Regulators clear the transfer, Rockwell takes ownership of the Medolla campus and the machine and concentrate lines, and Vantive keeps selling dialyzers alongside its new focus. The main test is whether transition and supply terms are settled in time for clinics to keep ordering machines and filters without interruption.

Discussed by: The announcement itself, which makes closing conditional on required regulatory approvals

The deal combines a concentrates supplier with a machine maker, and the overlap is small, but either U.S. or European authorities could extend review. A second-phase investigation would push closing past mid-2027 and leave clinics and Medolla workers in limbo longer.

Discussed by: Analysts quoted by Credence Research, who flag integration and debt-service burden

Vantive is financing the purchase through its own loans and a convertible note, so it is exposed to the business it is selling while Rockwell takes on a plant far larger than its current operations. If financing or integration costs run past expectations, the price or structure could be reopened, or the agreement terminated.